"Tenured Tier 1 Canada Research Chair / Tenure-Track or Tenured Faculty Position supported by a transformative $30M investment by Bruce Mitchell (Sc’68, DSc'20), the Mitchell Chair."

The Department of Biomedical and Molecular Sciences (DBMS) in Queen’s Health Sciences at Queen’s University invites applications for up to two tenure-track/tenured faculty positions at the rank of Assistant Professor, Associate Professor, or Full Professor as described below for each position. These co-ordinated hires are aimed at fostering research capacity in current and/or emerging areas of excellence at Queen’s University. Accordingly, the research strengths of the preferred candidates need to broadly complement at least one of the existing areas of research priority within the faculty, which include: (i) Inflammatory disease, (ii) Neuroimmunology (iii) Immunotherapeutic Development, and (iv) Data and Computational Sciences. The preferred start date for these positions is July 1, 2026.

The available positions are:

1. Tenured Tier 1 Canada Research Chair. Canada Research Chairs were established as part of a national strategy to foster research excellence (https://www.chairs-chaires.gc.ca/). Nominees for Tier 1 Chair positions must be full professors or associate professors who are expected to be promoted to the full professor level within one or two years of the nomination. Alternatively, if they come from outside the academic sector, nominees must possess the necessary qualifications to be appointed at these levels. The successful candidate must submit an external application to the Tri-agency Institutional Program Secretariat that meets the requirements for the successful nomination of a Tier 1 chair as defined by the Canada Research Chairs Program:

   • be outstanding and innovative world-class researchers whose accomplishments have made a major impact in their fields;
   • be recognized internationally as leaders in their fields;
   • have superior records of attracting and supervising graduate students and postdoctoral fellows (taking into account different practices in the relevant field or discipline) and, as chairholders, be expected to attract, develop and retain excellent trainees, students and future researchers; and
   • be proposing an original, innovative research program of the highest quality.

   CRC nominees are required to comply with the Government of Canada’s Policy on Sensitive Technology Research and Affiliations of Concern (STRAC). Applicants are encouraged to refer to the Government of Canada’s safeguarding your research website for further information on the identification and mitigation of security risks.

   Decreased teaching and administrative responsibilities will be associated with this position to enable the candidate to develop a world-class research program.

2. Tenure-Track or Tenured Faculty Position made possible by a transformative $30M investment by Bruce Mitchell (Sc’68, DSc'20). The successful candidate can be at the rank of assistant, associate or full professor. The successful candidate will receive direct research support for the first 5 years of their tenure from the Bruce Mitchell Research Program, including resources to support the recruitment of multiple postdoctoral researchers/students. Decreased teaching and administrative responsibilities will be associated with this position to enable the candidate to develop a world-class research program.

The Department of Biomedical and Molecular Sciences (DBMS)The DBMS is a research-intensive department with a diverse range of interests, from biophysics and drug development to neuroscience and cancer research. Queen’s boasts a large, modern non-human primate research facility including housing for 100+ animals, over a dozen behavioural assessment labs, surgical suites, and an adjacent and easily accessible MRI facility that houses a state-of-the-art Siemens Prisma system. Furthermore, DBMS offers a robust core facility that houses a brand-new top-of-the-line suite of flow cytometers, microscopes, and access to live animal imaging.

Recently, the Department established a strong immunology group with a focus on tissue repair, asthma, cancer, and pain. This has been supported by the recent recruitment of several scientists, including a Canada Excellence Research Chair (CERC) in immunophysiology and immunotherapy. Furthermore, we have established several Research Excellence Clusters. Those specific to this call include: 1) Tissue Inflammation and Repair, 2) Cancer Immunology & Immunotherapy, 3) Blood Research and Innovation Dynamic, and 4) GI and Liver Disease. Applicants should have expertise in research areas that complement these research clusters. Expertise in techniques such as intravital imaging, multiplex flow cytometry, and familiarity with omics data collection and analysis (including transcriptomics) would be advantageous.

Qualifications (both positions)Candidates must have a PhD or equivalent degree completed at the start date of the appointment. This is a requirement of the University and not the CRC program. The main criteria for selection are academic and scholarly excellence. The successful candidate will provide evidence of high-quality scholarly output that demonstrates potential for independent research leading to peer assessed publications and the securing of external research funding, as well as strong potential for training and mentoring graduate students and post-doctoral fellows, and an ongoing commitment to academic and pedagogical excellence in support of the Department’s programs. Candidates must provide evidence of an ability to work collaboratively in an interdisciplinary and student-centred environment. The successful candidate will also be expected to make positive contributions to the academic mission of the Department, the Faculty, the University, and/or the broader community. Salary will be commensurate with qualifications and experience.

How to ApplyThe University invites applications from all qualified individuals. Queen’s is strongly committed to employment equity, diversity and inclusion in the workplace and encourages applications from Black, racialized/visible minority and Indigenous people, women, persons with disabilities, and 2SLGBTQ+ persons.

Applicants who self-identify as members of these groups are strongly encouraged to do so to ensure equitable consideration in accordance with Canada Research Chairs Program guidelines. Self-identification is voluntary and confidential, managed by the Human Rights and Equity Office and one member of the selection committee who acts as the Employment Equity Representative.

We recognize that certain circumstances, including career interruptions, caregiving responsibilities, health conditions, or systemic barriers, may affect a nominee’s record of research achievement. Applicants are encouraged to provide relevant information to contextualize their research record.

Queen’s is committed to providing support and accommodation for applicants with disabilities at all stages of the recruitment processes. If you require accommodation for submitting your application or during the interview process, please contact Ms. Jackie Moore in the Department of Biomedical and Molecular Sciences at dbmsrecruit@queensu.ca.

In accordance with Canadian immigration requirements, Canadian citizens and permanent residents of Canada will be prioritized, including any qualified individuals who have a valid legal work status in Canada. Please indicate in your application if you have a valid legal work status in Canada. Applications from all qualified candidates will be considered in the applicant pool.

Those interested in this position should submit a complete application package, including the following documents:

• a cover letter (including: whether or not you have a valid legal work status in Canada; and whether your proposed research is advancing a Sensitive Technology Research Area with attestation to having no active affiliation with a Named Research Organization).
• a current Curriculum Vitae (including a list of publications with students clearly indicated and funding, secured and pending);
• a statement of research interests, including your research vision for the next 7 years;
• a statement of teaching interests and experience (including teaching outlines and evaluations if available); and,
• a statement of experience with, and commitment to, facilitation and promotion of I-EDIAA. Applicants may include examples such as mentoring students from underrepresented groups, designing inclusive curricula, promoting anti-racism in research and teaching, or collaborating with Indigenous communities.

Review of applications will begin on January 1, 2026 and will continue to be reviewed until suitable candidates are identified.

Applicants are asked to send all documents in their application packages electronically as PDFs to the attention of Dr. Katrina Gee at dbmsrecruit@queensu.ca. Hard copy applications may be submitted to Dr. Katrina Gee, Interim Department Head, Department of Biomedical and Molecular Sciences, Botterell Hall, Queen’s University, Kingston, Ontario, Canada, K7L 3N6.